Cited by 109Genetics and Neurodevelopmental DisordersGenomic variations and chromosomal abnormalitiesEpilepsy research and treatment

MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways

Open access
Paciorkowski, Alex R., Traylor, Ryan N., Rosenfeld, Jill A., Hoover, Jacqueline M., Harris, Catharine J., Winter, Susan, Lacassie, Yves, Bialer, Martin +13 more·2013·neurogenetics

Abstract

MEF2C haploinsufficiency syndrome is an emerging neurodevelopmental disorder associated with intellectual disability, autistic features, epilepsy, and abnormal movements. We report 16 new patients with MEF2C haploinsufficiency, including the oldest reported patient with MEF2C deletion at 5q14.3. We detail the neurobehavioral phenotype, epilepsy, and abnormal movements, and compare our subjects with those previously reported in the literature. We also investigate Mef2c expression in the developing mouse forebrain. A spectrum of neurofunctional deficits emerges, with hyperkinesis a consistent finding. Epilepsy varied from absent to severe, and included intractable myoclonic seizures and infantile spasms. Subjects with partial MEF2C deletion were statistically less likely to have epilepsy. Finally, we confirm that Mef2c is present both in dorsal primary neuroblasts and ventral gamma-aminobutyric acid(GABA)ergic interneurons in the forebrain of the developing mouse. Given interactions with several key neurodevelopmental genes such as ARX, FMR1, MECP2, and TBR1, it appears that MEF2C plays a role in several developmental stages of both dorsal and ventral neuronal cell types.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10048-013-0356-y

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A genome-wide ASD transcriptome study found the MEF2 splicing factor A2BP1/RBFOX1 as a hub in a downregulated synaptic-function gene network.

    “the MEF2 splicing factor ataxin-2-binding protein 1 (A2BP1; also known as RBFOX1) — previously implicated in ASD203,204 — was identified as a central hub within the network of downregulated genes associated with synaptic function.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Paciorkowski, A. R., Traylor, R. N., Rosenfeld, J. A., Hoover, J. M., Harris, C. J., Winter, S., Lacassie, Y., Bialer, M., Lamb, A. N., Schultz, R. A., Berry-Kravis, E., Porter, B. E., Falk, M., Venkat, A., Vanzo, R. J., Cohen, J. S., Fatemi, A., Dobyns, W. B., Shaffer, L. G., Ballif, B. C., & Marsh, E. D.
Affiliations
  • University of Rochester Medicine (US)
  • PerkinElmer (United States) (US)
  • University of Pittsburgh (US)
  • University of Missouri (US)
  • Children's Hospital Central California (US)
  • Children's Hospital of New Orleans (US)
  • Northwell Health (US)
  • University of Utah (US)
  • Stanford University (US)
  • Children's Hospital of Philadelphia (US)
  • Kennedy Krieger Institute (US)
  • University of Washington (US)
Corresponding author
Paciorkowski, Alex R.
Venue
neurogenetics
Published
2013-02-07
Volume
14
Issue
2
Pages
99-111
ISSN
  • 1364-6745 (ISSN-L)
  • 1364-6753
OpenAlex
W2140057847
Cited by
109
References
39
Citations by year
2026: 7 · 2025: 8 · 2024: 9 · 2023: 9 · 2022: 7 · 2021: 9 · 2020: 8 · 2019: 7 · 2018: 6 · 2017: 11 · 2016: 10 · 2015: 11 · 2014: 7
FWCI
6.19
Type
journal article
Language
en
Open access
Locations
  • Neurogenetics (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • ARUP Laboratories
  • Medical Center, University of Rochester
  • National Institute of Neurological Disorders and Stroke (K08NS078054, K02NS065975, R01NS058721)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
Keywords
hyperkinesia, epilepsy, intellectual disability, autism spectrum disorder, abnormal movements, infantile spasms, myoclonic seizures, forebrain development, GABAergic interneurons, ARX, FMR1 gene, MeCP2, Tbr1, neurodevelopmental disorders
MeSH terms
Adolescent, Adult, Animals, Child, Developmental Disabilities, Child, Preschool, Epilepsy, Female, Humans, Hyperkinesis, Infant, Interneurons, Male, Mice, Inbred C57BL, Middle Aged, Nerve Net, Phenotype, Gene Deletion, Mice, Young Adult, Haploinsufficiency, MEF2 Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review